https://www.selleckchem.com/pr....oducts/liothyronine-
limbs, including volume reduction and prevention of cellulitis. Therefore, a combination therapy might be useful for lymphedema cases at advanced stages.Purpose To define the current forms of treatment in a contemporary population of lymphedema (LED) patients for (1) LED related to breast cancer (BCRL), the most prevalently diagnosed LED comorbidity in Western countries, and (2) phlebolymphedema with venous leg ulcers (PLEDU), a sequela of chronic venous disease. Background The goals of LED therapy are to reduce edema, there